Literature DB >> 20072855

Pheochromocytoma in children and adolescents.

H K Ganesh1, Shrikrishna V Acharya, Joe Goerge, Tushar R Bandgar, Padma S Menon, Nalini S Shah.   

Abstract

Eleven subjects aged <20 yr with histologically proven pheochromocytoma between 1987 and 2006 were analyzed. Family history was present in 18%. In 2 patients, pheochromocytoma was part of VHL and in one it was associated with MEN 2. Twenty four hour urine VMA level was elevated in 100% and metanephrine level in 73%. CT/ MRI were showing the tumor in all. Prazosin extended release tablets (maximum 30 mg/day) were used in 73% and doxazosin (maximum 12 mg/ day) in 27%. Intraoperative BP fluctuations were seen in 27%. All were biochemically cured after surgery. Preoperative á blockade with extended release prazosin and doxazosin were effective in controlling perioperative BP fluctuations. Hence these drugs can be used in children and adolescents without fear of postoperative hypotension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072855     DOI: 10.1007/s12098-009-0287-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Pheochromocytoma in children and adolescents: an institutional experience.

Authors:  Anand K Misra; Gaurav Agarwal; Anjali Mishra; Amit Agarwal; Vijayalakshmi Bhatia; Saroj K Mishra
Journal:  Indian Pediatr       Date:  2002-01       Impact factor: 1.411

2.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

3.  Alpha blockade in preoperative preparation of patients with pheochromocytomas.

Authors:  Savas Kocak; Semih Aydintug; Necati Canakci
Journal:  Int Surg       Date:  2002 Jul-Sep

Review 4.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

5.  Pheochromocytoma: study of 50 cases.

Authors:  A M Lucon; M A Pereira; B B Mendonça; A Halpern; B L Wajchenbeg; S Arap
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

6.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

Review 7.  The evaluation and management of pheochromocytomas.

Authors:  S N Levine; J C McDonald
Journal:  Adv Surg       Date:  1984

8.  Pheochromocytoma and prazosin.

Authors:  J P Nicholson; E D Vaughn; T G Pickering; L M Resnick; J Artusio; H D Kleinert; J A Lopez-Overjero; J H Laragh
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Pheochromocytoma: state-of-the-art and future prospects.

Authors:  Emmanuel L Bravo; Rodrigo Tagle
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

  9 in total
  9 in total

1.  Recurrent Pheochromocytomas in a Child with Familial von Hippel-Lindau Syndrome.

Authors:  Djordje Savic; Maja Milickovic; Sladjana Todorovic; Miroslav Vukadin; Aleksandar Vlahovic; Blagoje Grujic; Mila Stajevic
Journal:  Indian J Pediatr       Date:  2016-04-29       Impact factor: 1.967

2.  Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.

Authors:  Sendhil Rajan; Ghazala Zaidi; Gaurav Agarwal; Anjali Mishra; Amit Agarwal; Saroj Kanta Mishra; Eesh Bhatia
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

Review 3.  Metastatic paraganglioma.

Authors:  Stephanie M J Fliedner; Hendrik Lehnert; Karel Pacak
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

4.  Pheochromocytoma management, outcomes and the role of cortical preservation.

Authors:  Alisha Gupta; Sandeep Agarwala; Nikhil Tandon; M Srinivas; Minu Bajpai; Devendra Kumar Gupta; Arun Kumar Gupta; Chandersekhar Bal; Rakesh Kumar; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-11-08       Impact factor: 1.967

Review 5.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

6.  Neurofibromatosis 1 with pheochromocytoma.

Authors:  K V S Hari Kumar; Altamash Shaikh; A S Sandhu; P Prusty
Journal:  Indian J Endocrinol Metab       Date:  2011-10

Review 7.  Characteristics of Pediatric Pheochromocytoma/paraganglioma.

Authors:  Vijaya Sarathi
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

8.  Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).

Authors:  Marie de Tersant; Lucile Généré; Claire Freyçon; Sophie Villebasse; Rachid Abbas; Anne Barlier; Damien Bodet; Nadège Corradini; Anne-Sophie Defachelles; Natacha Entz-Werle; Cyrielle Fouquet; Louise Galmiche; Virginie Gandemer; Brigitte Lacour; Ludovic Mansuy; Daniel Orbach; Claire Pluchart; Yves Réguerre; Charlotte Rigaud; Sabine Sarnacki; Nicolas Sirvent; Jean-Louis Stephan; Estelle Thebaud; Anne-Paule Gimenez-Roqueplo; Laurence Brugières
Journal:  J Endocr Soc       Date:  2020-04-03

9.  Reversible cerebral vasoconstriction syndrome (RCVS): an interesting case report.

Authors:  Mansoureh Togha; Mahsa Babaei; Parvin Ganji Ghelichi
Journal:  J Headache Pain       Date:  2021-04-06       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.